Clinical Trials Update: Dec. 26, 2006
Follicular Lymphoma Osteoarthritis Genital Herpes
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
You may be eligible for this clinical study of an investigational agent if you have follicular lymphoma and treatment has failed with rituximab in combination with chemotherapy, or with rituximab as a maintenance treatment.
The research site is in La Jolla, Calif.
This six-month study will evaluate the safety and effectiveness of an investigational agent compared to an inactive placebo in adults with daily moderate-to-severe knee pain due to osteoarthritis. Additional criteria apply.
The research site is in Boise, Idaho.
This study will evaluate an investigational medication to see if it reduces healing time for genital herpes outbreaks. To qualify, you must be at least 18, medically diagnosed with genital herpes, and be in good general health.
The research site is in Billings, Mont.
Copyright 2006 Thomson CenterWatch. All rights reserved.